{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:48Z","timestamp":1786991268153,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jad.2024.02.013","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T03:14:18Z","timestamp":1707448458000},"page":"895-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Impulse control behaviors and apathy commonly co-occur in de novo Parkinson's disease and predict the incidence of levodopa-induced dyskinesia"],"prefix":"10.1016","volume":"351","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.02.013_bb0005","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/mds.25832","article-title":"Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire","volume":"29","author":"Bolitho","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/mds.26208","article-title":"Apathy in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"30","author":"den Brok","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0015","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.parkreldis.2017.07.030","article-title":"The rise and fall of impulse control behavior disorders","volume":"46","author":"Cossu","year":"2018","journal-title":"Parkinsonism Relat D"},{"key":"10.1016\/j.jad.2024.02.013_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00415-019-09584-7","article-title":"Evolution of impulsive\u2013compulsive behaviors and cognition in Parkinson\u2019s disease","volume":"267","author":"Erga","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-018-0069-x","article-title":"Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort","volume":"4","author":"Eusebi","year":"2018","journal-title":"NPJ Parkinson's Disease"},{"key":"10.1016\/j.jad.2024.02.013_bb0035","article-title":"Impulse control disorders in Parkinson\u2019s disease","volume":"10","author":"Gatto","year":"2019","journal-title":"A Brief and Comprehensive Review. Front Neurol"},{"key":"10.1016\/j.jad.2024.02.013_bb0040","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0045","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s004150050530","article-title":"Risk factors for levodopa-induced dyskinesias in Parkinson\u2019s disease","volume":"246","author":"Grandas","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jad.2020.02.046","article-title":"Personalized prediction of depression in patients with newly diagnosed Parkinson\u2019s disease: a prospective cohort study","volume":"268","author":"Gu","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0055","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1007\/s00415-022-10963-w","article-title":"Levodopa-induced dyskinesia: a historical review of Parkinson\u2019s disease, dopamine, and modern advancements in research and treatment","volume":"269","author":"Hansen","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mdc3.13117","article-title":"Apathy and anxiety in De novo Parkinson\u2019s disease predict the severity of motor complications","volume":"8","author":"Hinkle","year":"2021","journal-title":"Mov Disord Clin Prac"},{"key":"10.1016\/j.jad.2024.02.013_bb0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2024.02.013_bb0070","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1212\/WNL.0000000000000385","article-title":"Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease","volume":"82","author":"Hong","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2024.02.013_bb0075","series-title":"A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep (New York, N.Y.)","first-page":"540","volume":"14","author":"Johns","year":"1991"},{"key":"10.1016\/j.jad.2024.02.013_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.3861","article-title":"Association of Cerebrospinal Fluid \u03b2-amyloid 1-42, T-tau, P-tau181, and \u03b1-Synuclein levels with clinical features of drug-naive patients with early Parkinson disease","author":"Kang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0085","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/jnnp-2019-322453","article-title":"Spectrum of impulse control behaviours in Parkinson\u2019s disease: pathophysiology and management","volume":"91","author":"Kelly","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.013_bb0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1037\/0022-006X.44.3.406","article-title":"The state-trait anxiety inventory: a systematic evaluation","volume":"44","author":"Kendall","year":"1976","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2024.02.013_bb0095","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.0b013e3182a4a503","article-title":"Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors","volume":"81","author":"Leentjens","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2024.02.013_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.parkreldis.2011.10.005","article-title":"Apathy and impulse control disorders in Parkinson\u2019s disease: a direct comparison","volume":"18","author":"Leroi","year":"2012","journal-title":"Parkinsonism Relat D"},{"key":"10.1016\/j.jad.2024.02.013_bb0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson progression marker initiative (PPMI)","volume":"95","author":"Marek","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jad.2024.02.013_bb0110","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00415-019-09692-4","article-title":"Dynamics of impulsive\u2013compulsive behaviors in early Parkinson\u2019s disease: a prospective study","volume":"267","author":"Markovi\u0107","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/ene.14169","article-title":"Impulse control and related behaviors in Parkinson\u2019s disease with dementia","volume":"27","author":"Martinez-Martin","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037632","article-title":"Diagnosis, treatment and management of apathy in Parkinson\u2019s disease: a scoping review","volume":"10","author":"Mele","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2024.02.013_bb0125","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jad.2024.02.013_bb0130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathy in Parkinson\u2019s disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1839\u20131851","key":"10.1016\/j.jad.2024.02.013_bb0135","first-page":"1988","article-title":"Prognostic factors for the progression of Parkinson\u2019s disease: a systematic review","volume":"22","author":"Post","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0140","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/mds.21537","article-title":"Prognostic factors for the progression of Parkinson\u2019s disease: a systematic review","volume":"22","author":"Post","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1468-1331.2009.02788.x","article-title":"Independent validation of the scales for outcomes in Parkinson\u2019s disease-autonomic (SCOPA-AUT)","volume":"17","author":"Rodriguez-Blazquez","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.parkreldis.2017.06.024","article-title":"Predictors of anxiety in early-stage Parkinson\u2019s disease \u2013 results from the first two years of a prospective cohort study","volume":"43","author":"Rutten","year":"2017","journal-title":"Parkinsonism Relat D"},{"key":"10.1016\/j.jad.2024.02.013_bb0155","doi-asserted-by":"crossref","first-page":"e2769","DOI":"10.1212\/WNL.0000000000010965","article-title":"Co-occurrence of apathy and impulse control disorders in Parkinson disease","volume":"95","author":"Scott","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2024.02.013_bb0160","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JPD-150535","article-title":"Apathy and impulse control disorders: yin & Yang of dopamine dependent behaviors","volume":"5","author":"Sierra","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jad.2024.02.013_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jnp.12013","article-title":"Impulsivity and apathy in Parkinson\u2019s disease","volume":"7","author":"Sinha","year":"2013","journal-title":"J. Neuropsychol."},{"key":"10.1016\/j.jad.2024.02.013_bb0170","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument","volume":"22","author":"Stiasny-Kolster","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","article-title":"Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment","volume":"11","author":"Svenningsson","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson\u2019s disease","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0185","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0190","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00702-018-1900-6","article-title":"Levodopa-induced dyskinesia: clinical features, incidence, and risk factors","volume":"125","author":"Tran","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jad.2024.02.013_bb0195","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update","volume":"16","author":"Voon","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0200","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson\u2019s disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.JGP.0000192488.66049.4b","article-title":"Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease","volume":"14","author":"Weintraub","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.013_bb0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0215","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease-rating scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2024.02.013_bb0220","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2024.02.013_bb0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12883-017-0874-6","article-title":"Clinical characteristics of impulse control and related disorders in Chinese Parkinson\u2019s disease patients","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jad.2024.02.013_bb0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/WCO.0000000000000209","article-title":"Developments in impulse control behaviours of Parkinson\u2019s disease","volume":"28","author":"Zurowski","year":"2015","journal-title":"Curr. Opin. Neurol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724003227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724003227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:56:24Z","timestamp":1720047384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724003227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"alternative-id":["S0165032724003227"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.02.013","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impulse control behaviors and apathy commonly co-occur in de novo Parkinson's disease and predict the incidence of levodopa-induced dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}